What You Should Know:
- Philips inks a collaboration with digital pathology
leader Proscia to advance an open ecosystem that helps laboratories accelerate
and scale digital pathology adoption.
- Proscia will integrate the Philips Pathology SDK to
natively utilize Philips’ iSyntax image format with its Concentriq digital
pathology platform and suite of AI modules, providing users of Philips’ digital
pathology solutions with expanded options to meet their business and
Read More
Digital Pathology
Paige Raises $45M to Expand AI-Native Digital Pathology Ecosystem to Accelerate Biomarker Discovery
- Paige raises $45M in Series B funding led by Healthcare Venture Partners with participation from Breyer Capital, Kenan Turnacioglu, and others. - The funding will be used to accelerate commercial efforts of its AI-native digital pathology ecosystem in the U.S., Europe, Brazil, and Canada. Paige, a NYC-based leader in computational pathology transforming the diagnosis and treatment of cancer, today announced it has closed its Series B funding round of $45 million, bringing the Company’s
Read More
Philips, Paige Partner to Deliver Clinical Grade AI Apps to Pathology Laboratories
- Philips and Paige form a strategic partnership to deliver AI-based cancer assessment tools are poised to help pathologists improve speed and accuracy of cancer diagnostics, ultimately leading to better patient care. - Philips IntelliSite Pathology Solution in combination with Paige Prostate aims to provide an intuitive digital & computational pathology workflow experience. Philips plans to offer the CE-marked Paige Prostate to European pathology labs in 2020.Philips today announced a
Read More
5 Ways Artificial Intelligence Is Transforming Digital Pathology
- As the digital pathology market grows, facilities that rely on digital pathology will start using artificial intelligence (AI) to assist. AI could help health professionals cope with the gigantic quantities of data - Discover why healthcare facilities increasingly realize that AI could help achieve significant impacts with digital pathology.Thanks to approvals from the Food and Drug Administration (FDA) for applications such as primary disease diagnosis, digital pathology is rapidly becoming
Read More
Philips to Create Taiwan’s First Fully Digital Pathology Department
Philips, today announced that Taipei Veterans General Hospital (TPVGH) will utilize the Philips IntelliSite Pathology Solution to establish Taiwan’s first fully digital pathology department. By allowing tissue samples to be remotely viewed within a virtual pathology network across hospital locations, the Philips IntelliSite Pathology Solution will help TPVGH enhance patient safety and improving the quality of diagnoses, thereby leading to better patient outcomes.Impact of Cancer in TaiwanCancer
Read More
Analysis: Philips’ Evolution to a Pure-play Healthcare Technology Vendor
The last two-to-three years we have seen Philips complete its transformation into a pure-play healthcare technology vendor. It has reduced its interest in its remaining non-healthcare business Philips Lighting/Signify (now owning only a 16.5% share), made 16 healthcare technology acquisitions since the start of 2017 and organized its internal business units into three core healthcare technology segments, Personal Health, Diagnosis & Treatment and Connected Care. A few weeks ago, several of
Read More
Mount Sinai, Philips, LabCorp to Launch Digital & AI-Enabled Pathology Center of Excellence
Mount Sinai, LabCorp, and Philips announced they are collaborating to establish the Mount Sinai Digital and Artificial Intelligence (AI)-Enabled Pathology Center of Excellence. The new center will feature the Philips IntelliSite Pathology Solution, the first digital pathology system FDA approved for primary diagnostic use, which will help the organizations enhance the quality and lower the costs of patient care.Role of LabCorpLabCorp will lead the integration of Philips’ system at Mount Sinai,
Read More
Deep Lens Lands $14M to Scale AI-Driven Digital Pathology Platform
Deep Lens, Inc., a Columbus, OH-based AI-driven digital pathology company focused on clinical trial recruitment at the time of diagnosis has raised $14 million in Series A funding. The Series A round was led by Northpond Ventures with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners. The funding comes months after Deep Lens emerged from stealth in October 2018 with a $3.2M seed round, which brings their funding to date total to $17.5
Read More
Proscia Raises $8M for AI-Enhanced Digital Pathology for Cancer Diagnosis
Proscia, a Philadelphia-based digital pathology platform has raised $8.3 million in Series A funding led by Boston-based Flybridge Capital Partners with participation from Emerald Development Managers, Fusion Fund, Razor’s Edge Ventures, and RobinHood Ventures.The startup plans to utilize the Series A funding to fuel the development and commercialization of new, clinical AI-enabled workflows targeting high-volume, high-impact cancers, the first of which will be available later this year. In
Read More
Philips Partners With Mass General to Advance Digital Pathology Adoption
Philips announced it’s collaborating with Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH) to enable research, support clinical diagnosis and help advance digital pathology adoption across the U.S. through the implementation of the Philips IntelliSite Pathology Solution.This collaboration builds on digital pathology’s growing momentum in recent years, due to its ability to enable highly automated workflows that allow pathologists to compile clinically actionable
Read More
